MHRA Guidelines: Aciclovir Safety in Pregnancy
MHRA Classification and Safety Profile
The Medicines and Healthcare products Regulatory Agency (MHRA) has extensively reviewed aciclovir's safety during pregnancy. Clinical studies involving over 1,000 pregnant women found no increased risk of birth defects when aciclovir was used for cold sore treatment. The medication crosses the placenta but reaches the baby in much lower concentrations than the mother receives.
When Aciclovir May Be Prescribed During Pregnancy
Healthcare providers may prescribe aciclovir during pregnancy for several scenarios. First-time cold sore outbreaks during pregnancy often require treatment as they tend to be more severe. Recurrent outbreaks near delivery may also warrant treatment to reduce transmission risk. Pregnant women with compromised immune systems may need aciclovir to prevent complications from herpes infections.
Available Treatment Options
EverydayMeds offers several aciclovir formulations suitable for pregnancy. Aciclovir 400mg tablets provide systemic treatment for severe outbreaks, whilst aciclovir 5% cream offers localised treatment with minimal absorption. Valaciclovir 500mg tablets represent an alternative option with better bioavailability, though aciclovir remains the first-line choice during pregnancy due to its extensive safety data.
Dosage Considerations During Pregnancy
Pregnancy dosages typically mirror standard recommendations but require medical supervision. For cold sore treatment, oral aciclovir is usually prescribed as 400mg three times daily for five days. Topical aciclovir cream should be applied five times daily to affected areas. Healthcare providers may adjust dosages based on outbreak severity and individual circumstances.
Breastfeeding Safety
Aciclovir is considered compatible with breastfeeding by the MHRA. Small amounts pass into breast milk, but levels are insufficient to harm nursing infants. The British National Formulary supports aciclovir use during lactation when clinically indicated. Mothers should continue prescribed treatment regimens whilst breastfeeding.
